BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chitadze G, Wehkamp U, Janssen O, Brüggemann M, Lettau M. The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells. Cancers (Basel) 2021;13:5947. [PMID: 34885056 DOI: 10.3390/cancers13235947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Bozorgmehr N, Hnatiuk M, Peters AC, Elahi S. Depletion of polyfunctional CD26(high)CD8(+) T cells repertoire in chronic lymphocytic leukemia. Exp Hematol Oncol 2023;12:13. [PMID: 36707896 DOI: 10.1186/s40164-023-00375-5] [Reference Citation Analysis]
2 Cordero OJ. CD26 and Cancer. Cancers 2022;14:5194. [DOI: 10.3390/cancers14215194] [Reference Citation Analysis]
3 Sebastián-martín A, Sánchez BG, Mora-rodríguez JM, Bort A, Díaz-laviada I. Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology. Biomedicines 2022;10:2026. [DOI: 10.3390/biomedicines10082026] [Reference Citation Analysis]
4 Li Z, Wang J, Yu Q, Shen R, Qin K, Zhang Y, Qiao Y, Chi Y. Identification of Immune-Related Gene Signature in Stanford Type A Aortic Dissection. Front Genet 2022;13:911750. [DOI: 10.3389/fgene.2022.911750] [Reference Citation Analysis]
5 Lettau M, Janssen O. Intra- and Extracellular Effector Vesicles From Human T And NK Cells: Same-Same, but Different? Front Immunol 2021;12:804895. [PMID: 35003134 DOI: 10.3389/fimmu.2021.804895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Verhulst E, Garnier D, De Meester I, Bauvois B. Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go? Cancers (Basel) 2022;14:624. [PMID: 35158891 DOI: 10.3390/cancers14030624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]